• Calpain, BDNF/TrkB, and Offspring Cognition

  2026-10-08

  A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy with excessive calpain activity, impaired hippocampal BDNF/TrkB signaling, and cognitive deficits in rat offspring. Pharmacological calpain inhibition or TrkB activation partially improved molecular, structural, and behavioral outcomes, supporting a mechanistic hypothesis while remaining limited to preclinical evidence.

• Bobcat339: TET Inhibition in Epigenetics

  2026-10-07

  Bobcat339 is a cytosine structure-based TET enzyme inhibitor reported to inhibit TET1 and TET2 in biochemical assays. Its value is strongest as a mechanistic epigenetics research compound, while its relevance to senile osteoporosis remains a hypothesis because the cited osteoporosis study did not report Bobcat339 as an intervention.

• SOD Activity Assay: Evidence, Uses, and Limits

  2026-10-07

  A source-grounded overview of Superoxide Dismutase Activity Assay Kit measurements, including the underlying colorimetric principle, research applications, evidence strength, comparison with hydrogen peroxide assays, and important interpretation limits.

• Primary Antibody Dilution Buffer in PCNSL Research

  2026-10-06

  Explore how Primary Antibody Dilution Buffer can support interpretable spatial follow-up of PCNSL single-cell discoveries. This article separates product attributes from biological evidence and examines how SLC2A5, fructose metabolism, hypoxia, and tumor–immune interactions should be interpreted across assay modalities.

• Pazopanib Hydrochloride: Research Evidence

  2026-10-06

  A source-grounded overview of Pazopanib Hydrochloride and GW786034, emphasizing its reported multi-kinase profile, the distinction between growth inhibition and cell death, conceptual applications in cancer research, and important evidence limitations.

• Trypsin as a Context-Controlled Research Reagent

  2026-10-05

  Trypsin is a serine protease whose value depends on biological context, not simply catalytic specificity. This article connects the research use of BA5744 with the R-loop and FTSJ3 findings in lung cancer while defining evidence boundaries for cell, membrane, and inflammation studies.

• Estradiol, ER Signaling, and CD4+ T-Cell Recovery

  2026-10-05

  Wang and colleagues identified endoplasmic reticulum stress as a mechanistic link between hemorrhagic shock and impaired splenic CD4+ T-lymphocyte function. Their receptor-selective experiments suggest that estradiol restores immune-cell activity mainly through ERα- and GPR30-associated signaling, rather than ERβ, providing a framework for studying post-traumatic immune dysfunction.

• EdU, NPC1, and the S-Phase Logic of HCC

  2026-10-04

  A translational perspective on using EdU-based DNA synthesis measurements to interrogate the NPC1/USP7/p53 axis in hepatocellular carcinoma, with emphasis on evidence strength, assay boundaries, and strategic validation.

• DFCP1 Controls ATGL-Driven Lipid Droplet Lipolysis

  2026-10-03

  The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of starvation-induced lipid droplet breakdown. Its central contribution is linking DFCP1 to ATGL recruitment and retention on lipid droplets, providing a mechanistic explanation for how cells tune lipolysis independently of better-known ATGL regulators.

• Cas12a mRNA: A Translational Validation Framework

  2026-10-02

  A mechanistic and strategic framework for evaluating Cas12a-encoding mRNA, connecting m1Ψ RNA chemistry, transient nuclease expression, guide performance, DNA repair, and translational decision-making.

• Superoxide Dismutase Activity Assay Kit Guide

  2026-10-01

  This guide explains how the Superoxide Dismutase Activity Assay Kit, SKU K2035, measures functional SOD activity through inhibition of WST-1 reduction by XO-generated superoxide. It is intended for research measurements in biological fluids, not for clinical diagnosis, direct superoxide concentration measurement, or unvalidated claims about SOD isoforms.

• Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance

  2026-10-01

  The reference study developed a tumor-microenvironment pH-responsive nanoparticle system for systemic delivery of PTEN mRNA to trastuzumab-resistant HER2-positive breast cancer. By restoring PTEN expression and restraining constitutive PI3K/Akt signaling, the platform provides a mechanistic strategy for resensitizing resistant tumors while highlighting the importance of stimulus-responsive delivery.

• Nitrocefin Assays for β-Lactamase Research

  2026-09-30

  Nitrocefin provides a rapid yellow-to-red readout for β-lactamase activity, supporting isolate screening, recombinant-enzyme kinetics, and inhibitor evaluation in one flexible workflow. This guide explains how to convert that chromogenic signal into reproducible data while avoiding solvent, timing, and substrate-specificity errors.

• SARS-CoV-2 PLpro Regulation of ER Proteins

  2026-09-30

  The reference study shows that membrane-anchored SARS-CoV-2 papain-like protease (PLpro) can both deubiquitinate and cleave endoplasmic reticulum proteins involved in lipid regulation. Its substrate-specific effects on INSIG-1, SREBP-1, and SREBP-2 reveal why PLpro activity cannot be understood solely through canonical viral cleavage or interferon-signaling models.

• GPNMB Model Predicts ESCC Immunotherapy Response

  2026-09-29

  This study identifies circulating soluble GPNMB as both a mechanistically relevant mediator of CD8+ T-cell exhaustion and a predictive biomarker for PD-1 blockade response in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors establish a multimodal framework with potential value for patient stratification and translational biomarker development.

7986 records 1/533 page Next 12345 下5页 Last page